CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 112,904	$ 30,294
Restricted cash	2,549	66,196
Patient accounts receivable	250,777	237,596
Prepaid expenses	14,906	8,243
Other current assets	30,114	8,225
Total current assets	411,250	350,554
Property and equipment, net of accumulated depreciation of $101,512 and $96,137	24,104	28,113
Operating lease right of use assets	94,273	84,791
Goodwill	931,483	658,500
Intangible assets, net of accumulated amortization of $17,165 and $7,044	84,143	64,748
Deferred income taxes	24,189	21,427
Other assets	33,278	54,612
Total assets	1,602,720	1,262,745
Current liabilities:
Accounts payable	39,037	31,259
Payroll and employee benefits	126,543	120,877
Accrued expenses	170,743	137,111
Provider relief fund advance	60,000	0
Current portion of long-term obligations	10,711	9,927
Current portion of operating lease liabilities	30,462	27,769
Total current liabilities	437,496	326,943
Long-term obligations, less current portion	300,576	232,256
Operating lease liabilities, less current portion	62,519	56,128
Other long-term obligations	44,386	5,905
Total liabilities	844,977	621,232
Commitments and Contingencies—Note 5
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,457,444 and 36,638,021 shares issued; and 32,802,785 and 32,284,051 shares outstanding	37	37
Additional paid-in capital	690,099	645,256
Treasury stock, at cost 4,654,659 and 4,353,970 shares of common stock	(318,771)	(251,241)
Accumulated other comprehensive income	0	15
Retained earnings	384,840	246,383
Total Amedisys, Inc. stockholders’ equity	756,205	640,450
Noncontrolling interests	1,538	1,063
Total equity	757,743	641,513
Total liabilities and equity	$ 1,602,720	$ 1,262,745